Statistical analysis found that the decreased expression of SCARA5 was correlated with tumor size (P = 0.0396), lymph node metastasis (P = 0.0254) and higher TNM stage (P = 0.0366), but not with patients' age, gender, Lauren's Classification, or differentiation status (Table 1). This evidence concerns the gene SCARA5 and neoplasm.